Record ID | marc_loc_2016/BooksAll.2016.part12.utf8:154529978:1248 |
Source | Library of Congress |
Download Link | /show-records/marc_loc_2016/BooksAll.2016.part12.utf8:154529978:1248?format=raw |
LEADER: 01248cam a2200289 i 4500
001 80016004
003 DLC
005 19990716000000.0
008 800505s1980 ne a b 101 0 eng
010 $a 80016004
020 $a044490154X (Elsevier)
040 $aDLC$cDLC$dDLC
050 00 $aRC685.C6$bI54 1979
060 $aW3 EX89 no. 516 1979 /$aW300I61 1979n
082 00 $a616.1/23061
111 2 $aInternational Adalat® Symposium,$b4th,$cParis,$d1979.
245 10 $aNew therapy of ischemic heart disease :$bproceedings of the symposium held at Paris, October 19-20, 1979 /$c4th International Adalat® Symposium ; edited by Paul Puech and Rolf Krebs.
260 $aAmsterdam ;$aPrinceton [N.J.] :$bExcerpta Medica ;$aNew York, N.Y. :$bsole distributors for the USA and Canada, Elsevier North-Holland,$c1980.
300 $axi, 298 p. :$bill. ;$c25 cm.
440 0 $aInternational congress series ;$vno. 516
504 $aIncludes bibliographical references and indexes.
650 0 $aCoronary heart disease$xChemotherapy$xCongresses.
650 0 $aNifedipine$xCongresses.
650 2 $aCoronary disease$xDrug therapy$xCongresses.
650 2 $aPyridines$xTherapeutic use$xCongresses.
700 1 $aPuech, Paul.
700 1 $aKrebs, Rolf,$d1940-